Results for parkinsoniżmu translation from Maltese to English

parkinsoniżmu
parkinsonism

parkinsoniżmu,
depression, anxiety

akatizja6 parkinsoniżmu
parkinsonism

5 tinkludi akatisja u parkinsoniżmu.
5 includes akathisia and parkinsonism.

parkinsoniżmu** sturdament distonija*** diskajneżja
parkinsonism** dizziness dystonia*** dyskinesia

parkinsoniżmu, uġigħ ta ’ ras, u insomnja.
parkinsonism, headache, and insomnia.

distonja diskajneżja tardiva parkinsoniżmu disturb taċ-ċaqlieq
tardive dyskinesia parkinsonism movement disorder

fi provi kliniċi pedjatriċi ta’ aripiprazole, ġew osservati akatisja u parkinsoniżmu.
in paediatric clinical trials of aripiprazole akathisia and parkinsonism were observed.

distonja akatixja diskinesija parkinsoniżmu sedazzjoni sturdament indeboliment fis-sens tat- togħma
dystonia akathisia dyskinesia parkinsonism sedation dizziness dysgeusia

parkinsoniżmu: ċaqliq bil-mod, b’rogħda, ebusija u mixja mkaxkra
parkinsonism: slow movements, with tremor, stiffness and a shuffling walk

mard ekstrapiramidali, parkinsoniżmu, rogħda, ipertonja, distonja, akatisja, sturdament, sedazzjoni, ħedla,
extrapyramidal disorder, parkinsonism, tremor, hypertonia, dystonia, akathisia, dizziness, sedation, somnolence,

skizofrenija - waqt studju ikkontrollat fit-tul ta’ 52 ġimgħa, pazjenti kkurati b’aripiprazole kellhom tnaqqis totali (25.8 %) ta’ eps li jinkludu parkinsoniżmu, akatiżja u diskineżja, meta mqabbla ma’ dawk ikkurati b’haloperidol (57.3 %).
schizophrenia: in a long term 52-week controlled trial, aripiprazole-treated patients had an overall- lower incidence (25.8%) of eps including parkinsonism, akathisia, dystonia and dyskinesia compared with those treated with haloperidol (57.3%).